• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹水的医学管理。

Medical management of ascites.

机构信息

University of Toronto, Toronto General Hospital, Department of Medicine, Ontario, Canada.

出版信息

Expert Opin Pharmacother. 2011 Jun;12(8):1269-83. doi: 10.1517/14656566.2011.549126. Epub 2011 Feb 10.

DOI:10.1517/14656566.2011.549126
PMID:21306283
Abstract

INTRODUCTION

Ascites is a common complication of advanced cirrhosis that has a significant negative impact on survival. This review updates the reader on the medical management of ascites.

AREAS COVERED

This review explores the pathophysiology of ascites formation in cirrhosis; the current mainstays of medical management (treating the underlying cause of cirrhosis, avoiding nephrotoxic agents, sodium restriction, and combination diuretic therapy); potential novel agents, such as vasoconstrictors and vaptans; and albumin infusions. The literature research covers all aspects of medical management of ascites from the English literature, concentrating on publications from the past 10 years. It provides a thorough understanding of how the correction of pathophysiology of ascites formation helps to improve ascites; knowledge on the monitoring of patients with cirrhosis and ascites receiving medical management, and on prophylaxis against potentially life-threatening complication such as spontaneous bacterial peritonitis; and potential new treatments for ascites.

EXPERT OPINION

Management of patients with cirrhosis and ascites requires careful attention to fluid and electrolyte balance and avoidance of complications. Recognition of refractory ascites allows for the use of second-line treatments. All patients with cirrhosis and ascites should be considered for liver transplantation.

摘要

简介

腹水是晚期肝硬化的常见并发症,对生存有显著的负面影响。本篇综述更新了读者对腹水的医学管理的认识。

涵盖领域

本篇综述探讨了肝硬化腹水形成的病理生理学;目前腹水的主要医学治疗方法(治疗肝硬化的根本原因、避免使用肾毒性药物、限制钠摄入和联合使用利尿剂治疗);潜在的新型药物,如血管收缩剂和血管加压素受体拮抗剂;以及白蛋白输注。文献研究涵盖了从英语文献中腹水的医学管理的各个方面,重点关注过去 10 年的出版物。它提供了对腹水形成的病理生理学的纠正如何有助于改善腹水的深入理解;了解接受医学治疗的肝硬化和腹水患者的监测,以及预防潜在危及生命的并发症(如自发性细菌性腹膜炎)的知识;以及腹水的潜在新治疗方法。

专家意见

肝硬化和腹水患者的管理需要仔细注意液体和电解质的平衡,并避免并发症。认识到难治性腹水可以使用二线治疗。所有肝硬化和腹水患者都应考虑进行肝移植。

相似文献

1
Medical management of ascites.腹水的医学管理。
Expert Opin Pharmacother. 2011 Jun;12(8):1269-83. doi: 10.1517/14656566.2011.549126. Epub 2011 Feb 10.
2
Review article: Management of ascites and associated complications in patients with cirrhosis.综述文章:肝硬化患者腹水及相关并发症的管理
Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:183-93. doi: 10.1111/j.1365-2036.2007.03482.x.
3
Ascites.腹水。
Clin Liver Dis. 2012 May;16(2):285-99. doi: 10.1016/j.cld.2012.03.004.
4
Fluid retention in cirrhosis: pathophysiology and management.肝硬化中的液体潴留:病理生理学与管理
QJM. 2008 Feb;101(2):71-85. doi: 10.1093/qjmed/hcm121. Epub 2008 Jan 9.
5
Ascites and spontaneous bacterial peritonitis: an Asian perspective.腹水与自发性细菌性腹膜炎:亚洲视角
J Gastroenterol Hepatol. 2009 Sep;24(9):1494-503. doi: 10.1111/j.1440-1746.2009.06020.x.
6
Treatment of ascites and spontaneous bacterial peritonitis - part I.腹水及自发性细菌性腹膜炎的治疗——第一部分
Dan Med J. 2012 Jan;59(1):C4371.
7
Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.肝硬化患者的腹水和自发性细菌性腹膜炎
Scand J Gastroenterol Suppl. 2006(243):79-84. doi: 10.1080/00365520600664342.
8
Management of ascites in cirrhosis.肝硬化腹水的管理
Clin Liver Dis. 2005 Nov;9(4):715-32, viii. doi: 10.1016/j.cld.2005.07.008.
9
Ascites in cirrhosis: a review of management and complications.肝硬化腹水:管理与并发症综述
Neth J Med. 2007 Sep;65(8):283-8.
10
Ascites: diagnosis and management.腹水:诊断与管理
Med Clin North Am. 2009 Jul;93(4):801-17, vii. doi: 10.1016/j.mcna.2009.03.007.

引用本文的文献

1
Kidneys in chronic liver diseases.慢性肝脏疾病中的肾脏。
World J Gastroenterol. 2012 Jun 28;18(24):3035-49. doi: 10.3748/wjg.v18.i24.3035.